D. E. Shaw & Co., Inc. Sight Sciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Sight Sciences, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 321,587 shares of SGHT stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

321,587

Holding current value

$1.29 Million

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.49 - $8.31 $239,715 - $362,847	-43,664 Reduced 11.95%	321,587 $2.03 Million
Q2 2024 Aug 14, 2024	SELL	$5.13 - $7.15 $46,970 - $65,465	-9,156 Reduced 2.45%	365,251 $2.44 Million
Q1 2024 May 15, 2024	SELL	$4.02 - $5.89 $122,320 - $179,220	-30,428 Reduced 7.52%	374,407 $1.98 Million
Q4 2023 Feb 14, 2024	BUY	$1.29 - $5.86 $183,363 - $832,952	142,142 Added 54.11%	404,835 $2.09 Million
Q3 2023 Nov 14, 2023	BUY	$2.88 - $8.8 $106,925 - $326,717	37,127 Added 16.46%	262,693 $885,000
Q2 2023 Aug 14, 2023	SELL	$7.46 - $10.67 $44,267 - $63,315	-5,934 Reduced 2.56%	225,566 $1.87 Million
Q1 2023 May 15, 2023	BUY	$8.44 - $13.35 $135,698 - $214,641	16,078 Added 7.46%	231,500 $2.02 Million
Q4 2022 Feb 14, 2023	BUY	$5.58 - $13.94 $770,631 - $1.93 Million	138,106 Added 178.63%	215,422 $2.63 Million
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $471,627 - $882,175	77,316 New	77,316 $491,000
Q4 2021 Feb 14, 2022	SELL	$17.36 - $27.36 $326,854 - $515,134	-18,828 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.34 - $39.1 $420,617 - $736,174	18,828 New	18,828 $427,000

Others Institutions Holding SGHT

# of Institutions

Shares Held

21.6M

Call Options Held

66.8K

Put Options Held

13K

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $192M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account